8110 Stock Overview

Operates an integrated online and offline platform in the healthcare market in the People's Republic of China. More details

8110 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 96.1% below our estimate of its fair value

Revenue is forecast to grow 9.76% per year

Earnings have grown 15.1% per year over the past 5 years

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€68M)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

111, Inc. Competitors

WASGAU Produktions & Handels

DB:MSH

€59.7m

Redcare Pharmacy

XTRA:RDC

€2.5b

Hawesko Holding

XTRA:HAW

€223.7m

Dingdang Health Technology Group

SEHK:9886

HK$475.0m

Price History & Performance

Summary of share price highs, lows and changes for 111
Historical stock prices
Current Share Price	US$6.70
52 Week High	US$9.65
52 Week Low	US$5.25
Beta	0.47
1 Month Change	5.51%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	45.65%

Recent updates

Shareholder Returns

	8110	DE Consumer Retailing	DE Market
7D	2.3%	0.5%	0.8%
1Y	n/a	10.2%	14.6%

Return vs Industry: Insufficient data to determine how 8110 performed against the German Consumer Retailing industry.

Return vs Market: Insufficient data to determine how 8110 performed against the German Market.

Price Volatility

Is 8110's price volatile compared to industry and market?
8110 volatility
8110 Average Weekly Movement	33.0%
Consumer Retailing Industry Average Movement	4.7%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.9%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: 8110's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 8110's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2010	1,238	Junling Liu	corporate.111.com.cn

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services.

111, Inc. Fundamentals Summary

How do 111's earnings and revenue compare to its market cap?
8110 fundamental statistics
Market cap	€61.34m
Earnings (TTM)	-€8.05m
Revenue (TTM)	€1.79b

0.0x

P/S Ratio

-7.6x

P/E Ratio

Is 8110 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8110 income statement (TTM)
Revenue	CN¥14.40b
Cost of Revenue	CN¥13.95b
Gross Profit	CN¥448.19m
Other Expenses	CN¥512.94m
Earnings	-CN¥64.74m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-7.47
Gross Margin	3.11%
Net Profit Margin	-0.45%
Debt/Equity Ratio	58.9%

How did 8110 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/16 23:40
End of Day Share Price	2025/05/16 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

111, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ruili Bian	Citigroup Inc
Yun Yin	J.P. Morgan
Robert Sassoon	Water Tower Research LLC

111 DB:8110 Stock Report